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Abstract
Heart failure (HF) is at present an important clinical problem. Hospitalization of HF patients causes that they have 
a much less favorable prognosis, and their successive rehospitalizations significantly affect the course of the disease 
and further treatment. The main reason for readmission to hospital is HF exacerbation, which from the pathophysiolo-
gical point of view is associated with an elevated pressure in the pulmonary circulation. Factors affecting rehospitali-
zation can be divided into: cardiac-related factors such as ischemia, atrial fibrillation, and uncontrolled hypertension, 
non-cardiac factors including coexisting diseases (especially chronic obstructive pulmonary disease, infections), patient-
-related factors (nonadherence/noncompliance, self-care, frailty-syndrome, depression, cachexia) and healthcare 
system-related factors (nonadherence of physicians, therapeutic nihilism, insufficiency of interdisciplinary care system 
in the field of patients’ therapy and education). Rehospitalization of HF patients is a complex, multifactorial and not 
fully understood problem. An integrated interdisciplinary care system, which covers patients’ therapy, education, self-
-assessment and self-control may reduce the mortality rate and number of rehospitalizations for all reasons and for HF.
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Introduction
Heart failure (HF) is an increasing epidemiological and 
clinical problem. The longer lifespan and higher survival 
rate of patients with acute coronary syndrome cause that 
the number of patients with this condition is growing. The 
incidence of chronic HF in Europe constitutes currently 
about 1–2% [1]; however, it noticeably increases with age 
— according to the report of the American Heart Associa-
tion (AHA) of 2013 [2] HF affects 7.8% of men and 4.5% of 
women over 60 years of age, and 8.6% of men and 11.5% of 
women over 80. What is striking, more than 80% of HF pa-
tients are over 65-year-olds. The incidence of HF is believed 
to increase by about 25% by 2030 comparing to 2013.
Despite many available pharmacotherapy options and 
the use of implantable medical devices, hospitalization 
of HF patients is still frequent. What is more, the survival 
rate in a group of patients with HFpEF (HF with preserved 
ejection fraction) has not improved, and only has slightly 
improved in patients with reduced ejection fraction [3].
The prognosis in chronic HF is unfavorable. One-year 
and five-year mortality rates have declined over recent 
years, but still remain high (according to epidemiological 
records, they are 11–30% and 41–65% respectively) [4]. 
A considerably worse prognosis and higher mortality rate 
are observed among hospitalized patients than those 
treated in outpatient clinics. Therefore, more and more 
attention is paid to the problem of rehospitalization for HF.
Hospitalizations due to HF can be divided into: hos-
pitalizations with a newly diagnosed or so called de novo 
HF (about 15%), hospitalizations for exacerbation of the 
disease (about 80%), and hospitalizations of so called 
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end-stage i.e. terminally ill patients (about 5%) [5]. As 
indicated by the statistics proposed by Jencks’s team [6], 
every fifth HF patient of Medicare was rehospitalized during 
30 days, and nearly every third — during 90 days since the 
last discharge from hospital. What is important, only 37% of 
rehospitalizations were associated with HF — the remainder 
was due to other diseases. It is also noticeable that about 
50% of patients hospitalized for HF have a preserved left 
ventricular ejection fraction (HFpEF) [6].
In the OPTIMIZE-HF (Organized Program to Initiate 
Lifesaving Treatment in Hospitalized Patients with Heart 
Failure) registry [4] a proportion of readmissions to hospital 
during 60–90 days from the discharge was about 30%, and 
a death rate in this period was 10%. The report based on 
the EVEREST (Efficacy of Vasopressin Antagonism in Heart 
Failure Outcome Study with Tolvaptan) [5] showed that 
58% of the first-time rehospitalizations took place more 
than 60 days after the last discharge; moreover, during 
this time it was an estimated 70% of all recorded deaths 
during the study. It must be emphasized that about 40% 
of hospitalizations were due to HF, and cardiovascular 
diseases altogether caused about 60% of hospitalizations.
Reasons for rehospitalization (Table 1) can be divid-
ed into: cardiac-related factors such as ischemia, atrial 
fibrillation, and uncontrolled hypertension, non-cardiac 
factors including coexisting diseases (chronic obstructive 
pulmonary disease, infections), patient-related factors 
(nonadherence/noncompliance, self-care, frailty-syndrome, 
depression, cachexia) and healthcare system-related fac-
tors (nonadherence of physicians, therapeutic nihilism, 
insufficiency of interdisciplinary care system in the field of 
patients’ therapy and education).
Heart failure as a cause of readmission to 
hospital
One of the main reasons for rehospitalization of HF patients 
is exacerbation of the disease. Both in the OPTIMIZE-HF 
registry and in the EVEREST program, HF was the most 
common cause of readmission to hospital (18% and 28% 
respectively). In the ADHERE (Acute Decompensated 
Heart Failure National Registry) [7] 24% of admissions to 
hospital were due to newly-diagnosed heart failure, and 
as many as 76% were associated with exacerbation of the 
previously diagnosed HF. It is currently observed that the 
main reason for rehospitalizations associated with exacer-
bation of HF is pulmonary congestion but not a low cardiac 
output [8]. Aside from left ventricular ejection fraction, 
clinical symptoms observed on admission to hospital are 
caused by pulmonary congestion. As typical symptoms of 
HF exacerbation, the ADHERE and OPTIMIZE-HF registers 
mention dyspnea (about 90%), rales (about 65%), and pe-
ripheral edema (about 65%). Pathophysiological changes 
in HF exacerbation manifest themselves as an increased 
left ventricular filling pressure. This may be caused by 
various factors such as arrhythmia, hypertensive crisis, 
myocardial ischemia, and cardiac valve dysfunction. What 
is important, an increased left ventricular filling pressure 
may occur many days before admission to hospital and 
have a subclinical course up to the emergence of symptoms 
and the necessity of hospitalization [9]. It may happen that 
patients are discharged from hospital after their clinical 
symptoms have subsided or have been alleviated, but an 
increased left ventricular filling pressure is still present. 
This in turn may lead to frequent rehospitalizations. In the 
IMPACT-HF (Initiation Management Predischarge Process 
for Assessment of Carvedilol Therapy for Heart Failure) 
study [10], about 60% of patients still had HF symptoms 
(dyspnea, fatigue) at discharge from hospital. After 60 days 
from discharge about 45% of these patients had another HF 
exacerbation, and 25% required readmission to hospital.
An increased left ventricular filling pressure is marked 
by high levels of natriuretic peptides. It was found in 
EVEREST trial [11] that patients who had sudden medical 
events soon after discharge from hospital, had also high 
levels of natriuretic peptides when they were discharged 
from hospital for the first time. It may suggest that though 
the symptoms of congestion were absent or significantly 
reduced at discharge from hospital, ‘hemodynamic con-
gestion’ or an increased left ventricular filling pressure 
was still present.
Table 1. Factors affecting rehospitalization of heart failure pa-
tients
Cardiac-related factors
Heart failure natural course and history
Exacerbating factors: ischemia, arrhythmias, especially atrial 
fibrillation, uncontrolled hypertension
Non-cardiac factors
Comorbidities (especially chronic obstructive pulmonary 
disease, infections)
Patient-related factors
Self-care
Nonadherence
Noncompliance
Frailty syndrome, cachexia, depression, cognitive disorders
Healthcare system-related factors
Nonadherence of physicians
Therapeutic nihilism
Insufficiency of interdisciplinary care system in the field of 
patients’ therapy, education
Self-assessment and self-control
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We currently lack appropriate diagnostic tests, which 
might be used to objectively confirm an increased left ven-
tricular filling pressure. Indirect methods include Doppler 
echocardiography, measurement of the levels of natriuretic 
peptides, and imaging with X-rays to check for symptoms 
of congestion in the pulmonary circulation. An objective 
examination which enables us to confirm an increased left 
ventricular filling pressure is the measurement of pulmo-
nary capillary wedge pressure (PCWP). Nevertheless, it is 
invasive and difficult to perform in a daily-routine clinical 
practice. Also serum biomarkers like impaired renal func-
tion, electrolyte metabolism disorders, anemia, high levels 
of natriuretic peptides, troponin and aminotransferases 
can be useful in determining patients with high risk of 
rehospitalization as they can show the beginning of the 
hemodynamic congestion. Hernandez et al. [12] showed 
that normal sodium levels (> 135 mmol/l) and reduction 
of N-terminal brain natriuretic peptide (NT-proBNP) at dis-
charge (net reduction > 23% compared to admission levels) 
were predictive of a lower rate of 30-day readmission for 
HF. In turn, patients with decreased renal function, defined 
as carry out, therefore its clinical usage is very limited.
However there are some predictive factors for hospital-
ization of HF. Those factors include sex, age, psychosocial 
factors (depression, unemployment, low income, the level 
of education), coexisting diseases (which are mentioned 
glomerular filtration rate [GFR] less than 45 mL/min per 
1.73 m2) were re-hospitalized more frequently than those 
with preserved renal function [13].
Comorbidities
Comorbidity is common among elderly people with chronic 
HF. The presence of many coexisting diseases delays and 
hinders a diagnosis of HF patients. What is more, additional 
health problems may affect the course and treatment of HF, 
through their contribution to hospitalizations and mortality 
rate in this group of patients.
Conditions which particularly contribute to hospital 
readmissions of HF patients are: chronic obstructive 
pulmonary disease, renal insufficiency, type 2 diabetes, 
depression and diseases of the lower respiratory tract. 
The study of Braunstein et al. [14] shows that the risk of 
hospitalization increases with the number of coexisting 
diseases. In the elderly HF population with a diagnosis of 
≥ 5 coexisting diseases, 40% of patients required rehospi-
talization more frequently than their healthier counterparts.
The above-mentioned OPTIMIZE-HF registry shows 
that patients hospitalized for pneumonia, acute coronary 
syndromes/ischemia, and deterioration in renal function 
were at the highest risk of intrahospital death. The risk 
of death after discharge from hospital was the highest 
for patients admitted to hospital due to acute coronary 
syndromes/ischemia and deterioration in renal function. 
What is important, all these conditions accompanying HF 
raise the risk of rehospitalization, which increases with 
their number [14].
Frailty syndrome
HF patients are mostly elderly people over 65 years of age. 
They are characterized by the coexistence of many diseases 
and clinical syndromes, including frailty syndrome (FS). 
Frailty syndrome is more common among HF patients than 
in the general population, and is an independent predictive 
factor for emergency interventions, hospitalization and 
mortality [15].
McNallan et al. [16] and Lupon et al. [17] demonstrated 
that patients with frailty syndrome were more often hos-
pitalized and more often visited the hospital emergency 
department.
As indicated by the Cardiovascular Health Study, the 
incidence of HF in patients with frailty syndrome was 
higher than in patients who were only at the risk of de-
veloping such syndrome, and in the latter it was higher 
than in those without frailty syndrome (14% vs. 4.6% vs. 
1.8%, p < 0.001) [18]. The results of the Women Health 
Initiative, on the other hand, showed that women with HF 
suffered from frailty syndrome six-seven times more often 
than those without HF [19].
The diagnosis of frailty syndrome in HF is of a great 
clinical importance, since it worsens the prognosis for 
the patients. In the study of Spanish population, the co-
existence of HF and frailty syndrome contributed to a rise 
in one-year mortality rate (16.9% in the group with frailty 
syndrome vs. 4.8% in the group without frailty syndrome, 
p < 0.001), and rehospitalizations (20.5% in the group 
with frailty syndrome vs. 13.3% in the group without frailty 
syndrome, p = 0.01) [17]. Similar results were obtained in 
the 12-year observation of Italian patients, in whom frailty 
syndrome was a predictor of a higher mortality rate [20].
A frequent coexistence of HF and frailty syndrome re-
sults from a common pathological background consisting 
of metabolic inflammatory processes and autonomic dis-
orders. As said by Afilalo et al. [21], frailty predisposes to 
myocardial damage, since it reduces stress resistance as 
a consequence of a decline in physiological reserve, and 
thus leads to HF decompensation and hospitalization. The 
research conducted by Pulignano et al. [22] demonstrated 
a significantly higher proportion of deaths (16.9% vs. 4.8%, 
p = 0.001) and a higher number of rehospitalizations 
(20.5% vs. 13.3%, p = 0.01) during one year.
The elderly with frailty syndrome and/or numerous co-
existing diseases not always receive full treatment for HF, 
which results both from real contraindications and physi-
cians’ fear. The use of angiotensin converting enzyme (ACE) 
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inhibitors and angiotensin receptor blockers (ARBs) is limit-
ed by renal failure, beta-blockers — by chronic obstructive 
pulmonary disease, vasodilators — the risk of orthostatic 
hypotension, and diuretics — the fear of urinary inconti-
nence, electrolyte disorders, progression of renal failure, 
and falls [23]. Additionally, patients with frailty syndrome 
are less mobile, and so they may encounter problems when 
getting to clinical centers. Impaired cognitive function, on 
the other hand, often results in worse adherence [23].
Cachexia
Cachexia is an important phenomenon in patients with HF 
and frailty syndrome. According to the Cachexia Consensus 
Conference in 2006, it is defined as a metabolic syndrome 
associated with the underlying disease and characterized 
by the weight loss ≥ 5% within one year (or decreased body 
mass index [BMI] < 20 kg/m2), as well as at least three 
out of five following criteria: reduction of muscle strength, 
fatigue, a poor appetite, low fat-free mass index, and ab-
normal biochemical test results (inflammation, anemia, 
low sodium level in serum) [24]. Cachexia in general, and 
specifically cardiac cachexia entail a higher frequency of 
hospitalizations and a very high risk of death [25]. Accord-
ing to the European Society of Cardiology (ESC), cachexia 
is observed in 10–15% of HF patients, especially those 
with reduced ejection fraction. Furthermore, the mortality 
rate of patients with chronic cardiac cachexia is 2–3 times 
higher than in the case of people with cachexia in general 
population [1].
Depression
Another factor which plays a crucial role in HF is depres-
sion. Depressive disorders are an essential part of frailty 
syndrome [26], but even depression itself increases the 
frequency of rehospitalizations of HF patients — according 
to Johnson et al. [27], depressed HF patients are rehospital-
ized one-and-a-half times more often than those without de-
pression, even if they cooperate with the doctors and take 
drugs regularly. Depression is significantly more common 
among people with HF and the New York Heart Association 
(NYHA) functional class III and class IV symptoms [28].
Cognitive function disorders
Impairment of cognitive function is common in elderly peo-
ple. Its incidence is estimated at about 25% [29]. Cognitive 
disorders and comorbidity are closely related to a higher 
number of hospitalizations and higher mortality rate among 
elderly HF patients.
Factors associated with cognitive disorders arouse 
some controversy. In their study of cognitive deficits in HF, 
Pressler et al. [30] demonstrated that age, sex and the 
severity of HF were significantly related to cognitive func-
tion. In another study, age, the level of hypertension, and 
depressive symptoms contributed to cognitive disorders 
in HF [31].
Patient-related factors
Self-care
An important aspect in all HF patients, and especially 
those with frailty syndrome is so-called self-care. It refers 
to patients’ appropriate behaviors concerning their health 
and education. These behaviors are defined as those that 
are exhibited by patients to be healthy and function well. 
They include adherence to/compliance with pharmacolo-
gical therapy, proper diet and regular exercises, as well as 
self-monitoring (everyday weighing and observing edema to 
check for increased fluid retention), reacting properly and 
searching for medical help when needed. Frailty syndrome 
affects all those behaviors, that is — the ability to self-care 
— especially in elderly patients with heart failure [32].
At present, there is little information about the influence 
of self-care on readmissions to hospital. As early as in 
1994 Dracup et al. [33] claimed that proper education of HF 
patients may reduce the number of their rehospitalizations. 
According to other authors, this effect is associated with 
regular drug administration [34]. On the contrary, Jaarsma 
et al. [35], who in 1999 compared the influence of health 
education provided by nurses on ‘self-care’ in a group of 
179 patients, did not demonstrate significant differences in 
the number or length of hospitalizations between educated 
and non-educated patients.
Numerous reports confirm that systematic education 
of HF patients plays an important part in the third-stage 
prevention, since it helps avoid decompensation and read-
missions to hospital [36]. It was also found that education 
is most effective if it is self-care oriented. Self-care in HF 
includes such aspects as taking appropriate doses of pre-
scribed medicines, modification of lifestyle (including diet 
and physical activity), and the ability to recognize the first 
symptoms of decompensation and react to them properly 
[37, 38]. Self-care level can be measured by appropriate 
scales, and those scales can show significant deficits in 
self-care behaviors which require to be optimized in future 
patient education [39].
Adherence
It is important to pay attention to non-adherence to 
medications and diet regimen, alcohol abuse, as well as 
overuse of over-the-counter (OTC) drugs (ex. non-steroidal 
anti-inflammatory drugs [NSAIDs]).
Both non-adherence to therapy and the lack of chang-
es in the lifestyle, which are observed in one third of HF 
patients, considerably contribute to HF exacerbation and 
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patients more often adhere to pharmacological therapy 
than change their lifestyles. The most effective treatment 
and high levels of compliance are achieved in these pa-
tients who go for checkups or take part in HF treatment 
programs [51].
A lack of cooperation on the patient’s part is common 
among elderly people and results in poor outcome [51]. 
Mockler et al. [52] demonstrated that discontinuation of 
the prescribed treatment was an independent predictor 
of rehospitalization for HF. Non-adherence to therapy was 
an independent factor associated with the higher mortality 
rate among the participants of the CHARM (Candesartan 
in Heart Failure Assessment of Reduction in Mortality and 
Morbidity) trial program [34]. Old age, frailty syndrome and 
comorbidity may contribute to non-adherence among HF 
patients, consequently leading to more frequent rehospi-
talizations, stays in long-term care institutions and finally 
death [23].
Healthcare system-related factors
The analysis of the Euro Heart Survey (EHS) shows that 
only 50% of HF population receives pharmacotherapy 
recommended by the ESC [53]. On average, primary care 
physicians prescribe ACE inhibitors to 40% of those who 
should receive them in accordance with the ESC guidelines 
(from 18% in Netherlands to over 50% in Germany) [53]. 
In Poland, ACE inhibitors are prescribed by primary care 
physicians to 54% of HF patients, which is slightly less than 
in the IMPROVEMENT study performed in general practice, 
in which the use of ACE inhibitors was 65% [54].
Considering beta-blockers, according to the EHS, the 
therapy was initiated by primary care physicians only in one 
fifth of patients [53]. In the countries of Western Europe 
(Switzerland, France and Netherlands) these drugs belong 
to the least frequently used by primary care physicians (only 
in about 9% of patients), while in Germany and Hungary it 
is 70% and 71% respectively. In Poland it is 30%.
Therapeutic nihilism is responsible for a substantial 
number of hospitalizations for HF [55]. There is the need 
for continuous education of the medical environment on 
HF therapy related issues [56].
Modern methods of management of HF patients, 
based on the integrated healthcare system, have the 
task of improving the quality and comfort of patients’ 
lives, slowing the progress of the disease, preventing 
frequent rehospitalizations, and cutting the huge costs 
of treatment. To achieve this goal, comprehensive health 
education is needed [57]. Integrated healthcare programs 
may be based on HF outpatient clinics, home visits, con-
sultations by phone and telemonitoring. The majority of 
programs do not include all these elements, but using at 
least one of them may be of benefit to patients. Education 
of patients and interventions for supporting them reduce 
the number and cost of hospitalizations for HF [58]. The 
increase the cost of therapy [40]. According to litera-
ture, non-adherence to the prescribed treatment affects 
40–60% of HF patients.
Nieuwenhuis et al. [41] demonstrated that 72% of HF 
patients adhere to four out of six therapeutic recommen-
dations. Those most often obeyed are pharmacological 
therapy (98%) and check-ups (95%), and the least — low-so-
dium diet regimen (79%), limitation of fluid intake (73%), 
and everyday weighing (35%).
Based on one of prospective studies, patients who 
adhered to nonpharmacological recommendations were 
less often hospitalized for HF, and their stays in hospital 
were shorter than it was in the case of patients who had 
not fully cooperated with medical professionals [42]. The 
number of rehospitalizations was also significantly related 
to regular physical exercises. Davies et al. [43] have shown 
that participation of HF patients in cardiac rehabilitation 
reduced the number of rehospitalizations for HF.
What is interesting, no relationship was observed be-
tween rehospitalizations or mortality rate and adherence 
to diet and fluid intake regimen. However, the randomized 
study [44] comparing low-sodium and normal-sodium diets 
followed by patients taking high doses of furosemide, 
revealed that those who limited sodium intake were more 
often hospitalized. It was associated with changes in the 
renin–angiotensin–aldosterone (RAA) system, occurring 
while being on a low-sodium diet.
In the study of Evangelista et al. [45], the risk of rehos-
pitalization was higher for those HF patients who did not 
follow recommendations concerning smoking and alcohol 
consumption. Nonrandomized observations, on the other 
hand, demonstrated the relationship between more fre-
quent hospitalizations and not getting a flu vaccination by 
patients over 65 years of age [46].
Muray et al. [47] noted a three times higher frequency 
of rehospitalizations among HF patients who did not follow 
a therapeutic regimen.
One of the most common causes of patients’ non-adhe-
rence is their inability to keep to the doctor’s orders. Patients 
claim that instructions given to them are too complicated 
and inapplicable (71%). The most common reason for not 
taking recommended medicines is their lack or problems 
with getting the next prescription (33%). Every fifth patient 
complains of adverse side-effects of therapy (20%), mem-
ory disorders (18%) and financial barriers [48].
According to World Health Organization (WHO), factors 
which hinder patients’ compliance and adherence are 
physical disability and cognitive dysfunction, especially 
among elderly people. HF patients often suffer from de-
pressive symptoms and cognitive disorders, and people 
with depression are less careful about taking drugs [49]. 
Patients with depressive symptoms miss doses of medi-
cations more frequently than those without depression 
(75% vs. 21%, p < 0.01) [50]. Studies also show that HF 
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multidisciplinary healthcare program for HF patients, 
carried out by McDonald et al. [59] in one of Irish clinics, 
demonstrated a decline in the number of rehospitaliza-
tions and deaths from HF during 90 days from discharge 
from hospital. The team included a cardiologist, a nurse 
and a dietitian.
Meta-analyses of randomized programs of care for HF 
patients, and the results of the multidisciplinary program 
implemented in Poznań, PL in 2002 confirm favorable 
effects of therapy based on new interdisciplinary care 
programs.
After one-year observation, Wierzchowiecki et al. [60] 
noted a decrease in the total and HF mortality rates, low-
er frequency of hospitalizations and improvement of the 
quality of life. Meta-analysis of 33 randomized studies 
conducted by Roccaforte et al. [61] revealed a decline in 
the total and HF mortality rates, as well as a reduction of 
the number of rehospitalizations for both HF and other 
health problems. The above mentioned programs also 
demonstrated that the cost of treatment decreased and 
the quality of life improved. Similar results were obtained by 
McAlister et al. [62] in their meta-analysis of 29 randomized 
studies. An integrated system of interdisciplinary care 
reduces mortality rate and the number of readmissions to 
hospital for both HF and other diseases.
As results from the above mentioned studies, interdis-
ciplinary care programs noticeably improve the treatment 
process of HF patients. Comprehensive education of pa-
tients and their families is the most essential part of inter-
disciplinary care [63]. As part of such education, patients 
should be informed about the nature of their disease, its 
symptoms, and the ways of monitoring decompensation 
symptoms. Education should be provided during patients’ 
stay in hospital, and after discharge it should be continued 
in heart failure outpatient clinics. Education of patients and 
their families or caregivers should consist of individual and 
group conversations, interactive workshops, multimedia 
displays, lectures and printed materials. Van der Wal et 
al. [64] reported that out of 501 HF patients, 73% kept 
to fluid-intake regime, merely 35% weighed themselves 
regularly, as many as 80% believed that physical exercis-
es were an important element of the lifestyle, but only 
39% of them took physical activity. Education provided as 
a part of healthcare programs for HF patients should cover 
such issues as pharmacotherapy, diet, using alcohol and 
cigarettes, physical effort, sexual activity and obligatory 
vaccinations.
Summary
Rehospitalization of HF patients is a complex, multifactorial 
and not fully understood problem. An integrated interdis-
ciplinary care system, which covers patients’ therapy, 
education, self-assessment and self-control may reduce 
the mortality rate and number of rehospitalizations for all 
reasons and for HF.
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Streszczenie
Niewydolność serca (HF) jest obecnie ważnym problemem klinicznym. Rehospitalizacje chorych z HF są jedną z przyczyn 
gorszego rokowania, wpływają na przebieg choroby i dalsze leczenie. Główną przyczyną readmisji do szpitala jest za-
ostrzenie HF, które z patofizjologicznego punktu widzenia wiąże się z podwyższonym ciśnieniem w kapilarach płucnych. 
Czynniki wpływające na rehospitalizacje można podzielić na: związane z układem krążenia (takie jak niedokrwienie, 
migotanie przedsionków czy niekontrolowane nadciśnienie tętnicze), niezwiązane z układem krążenia (choroby współist-
niejące, w szczególności przewlekła obturacyjna choroba płuc czy infekcje), związane z pacjentem (takie jak współpraca 
i stosowanie się do zaleceń leczniczych, samokontrola, zespół kruchości, zaburzenia poznawcze, depresja, kacheksja), 
związane z systemem opieki zdrowotnej (takie jak niewydolność systemu opieki w zakresie edukacji i leczenia, nihilizm 
terapeutyczny). Rehospitalizacje chorych z HF są złożonym, wieloczynnikowym i nie do końca poznanym problemem. 
Zintegrowana wielodyscyplinarna opieka nad chorym, uwzględniająca także edukację pacjenta oraz jego samoocenę 
i samokontrolę, może zmniejszyć liczbę rehospitalizacji i śmiertelność ogólną chorych z HF.
Słowa kluczowe niewydolność serca, rehospitalizacje
Folia Cardiologica 2017; 12, 2: 162–170
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